John Stossel on Corporate Money in Science


Lately, activists have become obsessed with "conflict of interest" in science—any trace of corporate money must poison honest medical research. Obamacare includes a rule called the Physician Payment Sunshine Act, which orders companies that make medical products to disclose even bagels they serve doctors and anything valued above $10.
But rules like these only make life more difficult for doctors, and for patients who want cures, argues John Stossel. Markets do not automatically taint science. As with every other service the market provides, it is the anti-capitalist attitude that does more harm.
Hide Comments (0)
Editor's Note: As of February 29, 2024, commenting privileges on reason.com posts are limited to Reason Plus subscribers. Past commenters are grandfathered in for a temporary period. Subscribe here to preserve your ability to comment. Your Reason Plus subscription also gives you an ad-free version of reason.com, along with full access to the digital edition and archives of Reason magazine. We request that comments be civil and on-topic. We do not moderate or assume any responsibility for comments, which are owned by the readers who post them. Comments do not represent the views of reason.com or Reason Foundation. We reserve the right to delete any comment and ban commenters for any reason at any time. Comments may only be edited within 5 minutes of posting. Report abuses.
Please
to post commentsMute this user?
Ban this user?
Un-ban this user?
Nuke this user?
Un-nuke this user?
Flag this comment?
Un-flag this comment?